Philip Morris International CapEx decreased by 20.5% to $353.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.6%, from $404.00M to $353.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 20.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $128.00M | $152.00M | $289.00M | $229.00M | $249.00M | $252.00M | $347.00M | $279.00M | $360.00M | $371.00M | $311.00M | $417.00M | $370.00M | $379.00M | $278.00M | $404.00M | $356.00M | $365.00M | $444.00M | $353.00M |
| QoQ Change | — | +18.8% | +90.1% | -20.8% | +8.7% | +1.2% | +37.7% | -19.6% | +29.0% | +3.1% | -16.2% | +34.1% | -11.3% | +2.4% | -26.6% | +45.3% | -11.9% | +2.5% | +21.6% | -20.5% |
| YoY Change | — | — | — | — | +94.5% | +65.8% | +20.1% | +21.8% | +44.6% | +47.2% | -10.4% | +49.5% | +2.8% | +2.2% | -10.6% | -3.1% | -3.8% | -3.7% | +59.7% | -12.6% |